Cynthia M. Butitta, Chief Operating Officer at Kite Pharma, Inc. (KITE), sold 15,000 shares at $120.52 ($1.8M) on 2017-08-10, disclosed to the SEC on 2017-08-14.
Open-market sale of $1.8M KITE by Chief Operating Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $120.52 | 9,200 | $1.1M | 61.2% |
| 2 | $121.03 | 5,800 | $702K | 38.8% |
| Total | $120.72 avg | 15,000 | $1.8M | 100% |
| Filing → |
| KITE | SELL | 2017-06-27 | $711K | — | Filing → |
| KITE | SELL | 2017-06-12 | $885K | — | Filing → |
| KITE | SELL | 2017-04-27 | $2.5M | — | Filing → |